These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 20178797)

  • 1. Persistence of cognitive impairment after resolution of overt hepatic encephalopathy.
    Bajaj JS; Schubert CM; Heuman DM; Wade JB; Gibson DP; Topaz A; Saeian K; Hafeezullah M; Bell DE; Sterling RK; Stravitz RT; Luketic V; White MB; Sanyal AJ
    Gastroenterology; 2010 Jun; 138(7):2332-40. PubMed ID: 20178797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistence of cognitive impairment after resolution of overt hepatic encephalopathy.
    Umapathy S; Dhiman RK; Grover S; Duseja A; Chawla YK
    Am J Gastroenterol; 2014 Jul; 109(7):1011-9. PubMed ID: 24777152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overt hepatic encephalopathy impairs learning on the EncephalApp stroop which is reversible after liver transplantation.
    Acharya C; Wade JB; Fagan A; White M; Gavis E; Ganapathy D; Gilles H; Heuman DM; Bajaj JS
    Liver Transpl; 2017 Nov; 23(11):1396-1403. PubMed ID: 28885772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased risk of cognitive impairment in cirrhotic patients with bacterial infections.
    Merli M; Lucidi C; Pentassuglio I; Giannelli V; Giusto M; Di Gregorio V; Pasquale C; Nardelli S; Lattanzi B; Venditti M; Riggio O
    J Hepatol; 2013 Aug; 59(2):243-50. PubMed ID: 23523580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective comparative study of inhibitory control test and psychometric hepatic encephalopathy score for diagnosis and prognosis of minimal hepatic encephalopathy in cirrhotic patients in the Indian subcontinent.
    Gupta D; Ingle M; Shah K; Phadke A; Sawant P
    J Dig Dis; 2015 Jul; 16(7):400-7. PubMed ID: 25858627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential impact of hyponatremia and hepatic encephalopathy on health-related quality of life and brain metabolite abnormalities in cirrhosis.
    Ahluwalia V; Wade JB; Thacker L; Kraft KA; Sterling RK; Stravitz RT; Fuchs M; Bouneva I; Puri P; Luketic V; Sanyal AJ; Gilles H; Heuman DM; Bajaj JS
    J Hepatol; 2013 Sep; 59(3):467-73. PubMed ID: 23665182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive dysfunction is associated with poor socioeconomic status in patients with cirrhosis: an international multicenter study.
    Bajaj JS; Riggio O; Allampati S; Prakash R; Gioia S; Onori E; Piazza N; Noble NA; White MB; Mullen KD
    Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1511-6. PubMed ID: 23707462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of HE history, HE status and neuropsychological test type on learning ability in patients with cirrhosis.
    Zarantonello L; Turco M; Formentin C; Izquierdo-Altarejos P; Vuerich A; Barcenas Jimenez MJ; Montoliu C; Felipo V; Angeli P; Amodio P; Montagnese S
    Liver Int; 2019 May; 39(5):861-870. PubMed ID: 30658006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant topological organization of the functional brain network associated with prior overt hepatic encephalopathy in cirrhotic patients.
    Chen HJ; Chen QF; Yang ZT; Shi HB
    Brain Imaging Behav; 2019 Jun; 13(3):771-780. PubMed ID: 29846883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disrupted topological organization of brain structural network associated with prior overt hepatic encephalopathy in cirrhotic patients.
    Chen HJ; Shi HB; Jiang LF; Li L; Chen R
    Eur Radiol; 2018 Jan; 28(1):85-95. PubMed ID: 28667481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory control test is a simple method to diagnose minimal hepatic encephalopathy and predict development of overt hepatic encephalopathy.
    Bajaj JS; Saeian K; Verber MD; Hischke D; Hoffmann RG; Franco J; Varma RR; Rao SM
    Am J Gastroenterol; 2007 Apr; 102(4):754-60. PubMed ID: 17222319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Post-Traumatic Stress Disorder on Cognitive Function and Covert Hepatic Encephalopathy Diagnosis in Cirrhotic Veterans.
    Burroughs TK; Wade JB; Ellwood MS; Fagan A; Heuman DM; Fuchs M; Bajaj JS
    Dig Dis Sci; 2018 Feb; 63(2):481-485. PubMed ID: 29313245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic Encephalopathy Is Associated with Persistent Learning Impairments Despite Adequate Medical Treatment: A Multicenter, International Study.
    Nardelli S; Allampati S; Riggio O; Mullen KD; Prakash R; Gioia S; Unser A; White MB; Fagan AC; Wade JB; Farcomeni A; Gavis EA; Bajaj JS
    Dig Dis Sci; 2017 Mar; 62(3):794-800. PubMed ID: 28039670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory control test for the diagnosis of minimal hepatic encephalopathy.
    Bajaj JS; Hafeezullah M; Franco J; Varma RR; Hoffmann RG; Knox JF; Hischke D; Hammeke TA; Pinkerton SD; Saeian K
    Gastroenterology; 2008 Nov; 135(5):1591-1600.e1. PubMed ID: 18723018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive impairment and electroencephalographic alterations before and after liver transplantation: what is reversible?
    Campagna F; Montagnese S; Schiff S; Biancardi A; Mapelli D; Angeli P; Poci C; Cillo U; Merkel C; Gatta A; Amodio P
    Liver Transpl; 2014 Aug; 20(8):977-86. PubMed ID: 24809329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance characterization of a novel electronic number connection test to detect minimal hepatic encephalopathy in cirrhotic patients.
    Wuensch T; Ruether DF; Zöllner C; Mueller T; Jung T; Kaffarnik M; Kassner U; Schott E; Kiefer S; Pratschke J; Stockmann M; Jara M
    Eur J Gastroenterol Hepatol; 2017 Apr; 29(4):456-463. PubMed ID: 28092641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive performance as a predictor of hepatic encephalopathy in pretransplant patients with cirrhosis receiving psychoactive medications: a prospective study.
    Bajaj JS; Thacker LR; Heuman DM; Sterling RK; Stravitz RT; Sanyal AJ; Luketic V; Fuchs M; Gilles HC; Wade JB
    Liver Transpl; 2012 Oct; 18(10):1179-87. PubMed ID: 22674517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary prophylaxis of hepatic encephalopathy in cirrhosis: an open-label, randomized controlled trial of lactulose, probiotics, and no therapy.
    Agrawal A; Sharma BC; Sharma P; Sarin SK
    Am J Gastroenterol; 2012 Jul; 107(7):1043-50. PubMed ID: 22710579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary prophylaxis of overt hepatic encephalopathy in patients with cirrhosis: an open labeled randomized controlled trial of lactulose versus no lactulose.
    Sharma P; Sharma BC; Agrawal A; Sarin SK
    J Gastroenterol Hepatol; 2012 Aug; 27(8):1329-35. PubMed ID: 22606978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of overt hepatic encephalopathy by the continuous reaction time method and the portosystemic encephalopathy syndrome test in clinically mentally unimpaired patients with cirrhosis.
    Wernberg CW; Schaffalitzky de Muckadell OB; Vilstrup H; M Lauridsen M
    PLoS One; 2019; 14(12):e0226283. PubMed ID: 31830113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.